CONFERENCE
June 20-21, 2023 | Philadelphia
Panel:
Tuesday, June 20
2:10PM – 3:10PM
Multiomics in Neurodegenerative Diseases
Speakers:
Yuling Luo, PhD
Founder, President & CEO, Alamar Bio
CONFERENCE
June 20-23, 2023 | Boston
Booth# 8
Industry Tutorial:
Wednesday, June 21
11:45AM-12:45PM
Advances in blood-based profiling of immune response biomarkers
Speakers:
Holden T. Maecker, PhD
Professor of Microbiology and Immunology, Stanford University
Christopher Bunker, PhD
VP of Biopharma Business Development, Alamar Bio
Webinar
May 25, 2023 – 12:00PM EST
Inflammatory Protein Signatures Associated with Proneness to Early Life Infection and Asthma
Speakers:
Jessica Lasky-Su, DSc, MS
Associate Professor in Medicine and associate statistician at Harvard Medical School and Brigham and Women’s Hospital
May 11-15, 2023 | Washington, D.C.
Booth# 7144
Workshop:
Friday, May 12
1:45PM-2:30PM – Room 3
Speakers:
Susanne Schmidt, PhD
Principal Investigator
Institute of Innate Immunity
University Hospital Bonn
April 25-27, 2023 | Boston
NULISA: Ultra-sensitive immunoassay platform for fluid-based neurodegenerative biomarker detection
Speakers:
Christopher Bunker, PhD
VP, Biopharma Business Development
Alamar Biosciences
Webinar
April 19, 2023 – 4:10-5:00PM EST
NULISA: A precision proteomics platform with ultra-high sensitivity and high multiplex for liquid biopsy samples.
Speakers:
Alex Forrest-Hay
VP of Sales, Alamar Biosciences
Alamar Biosciences, Inc.
47071 Bayside Pkwy
Fremont, CA 94538
1 (510) 626-9888
Fax: (510) 605-5062
